Ilan Ganot sold $448 of SLDB
director at Solid Biosciences Inc.. 144 shares at an average of $3.11, traded Jan 28, 2025, filed Jan 29, 2025.
Score components
- +15RoleDirector
- 0Trade size$448 at market
- 0Share of holdings soldSold 1.2% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-010625, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 27, 2025 | MOption exercise Common Stockindirect: Wife10b5-1 | +388 | - | - | 11,833 | Jan 29, 2025 |
| Jan 28, 2025 | SOpen-market sale Common Stockindirect: Wife10b5-1 | -144 | $3.11 | $448 | 11,689 | Jan 29, 2025 |
| Jan 27, 2025 | MOption exercise Common Stock10b5-1 | +3,883 | - | - | 98,690 | Jan 29, 2025 |
| Jan 27, 2025 | MOption exercise Restricted Stock Unitsderivativeindirect: Wife10b5-1 | -388 | $0.00 | $0 | 389 | Jan 29, 2025 |
| Jan 27, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -3,883 | $0.00 | $0 | 3,884 | Jan 29, 2025 |
Related signals
Other insiders at Solid Biosciences Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | SLDBbuy Solid Biosciences Inc. | Clare Kahn director | $9,924 1,860 shares | +169% | |
| 53Moderate | Solid Biosciences Inc. | Bain Capital Life Sciences Investors, LLC owner | $4.0M 1,000,000 shares | +25% | |
| 65Notable | Solid Biosciences Inc. | Perceptive Advisors LLC director, owner | $20M 5,000,000 shares | +73% | |
| 50Moderate | Solid Biosciences Inc. | Adage Capital Management, L.P. owner | $1.9M 252,545 shares | +6% | |
| 0Weak | Solid Biosciences Inc. | Gabriel Brooks Chief Medical Officer | $13k 3,256 shares | -12% | |
| 16Weak | Solid Biosciences Inc. | Alexander Cumbo President and CEO | $45k 11,365 shares | -16% | |
| 0Weak | Solid Biosciences Inc. | Ilan Ganot director | $6,776 1,711 shares | -10% | |
| 0Weak | Solid Biosciences Inc. | Jessie Hanrahan Chief Regulatory Officer | $12k 3,079 shares | -14% | |
| 0Weak | Solid Biosciences Inc. | Paul Herzich Chief Technology Officer | $11k 2,688 shares | -13% | |
| 5Weak | Solid Biosciences Inc. | David T Howton Chief Operating Officer | $22k 5,561 shares | -18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.